PROSTATE CANCER DETECTION IN THE PROSTATE SPECIFIC ANTIGEN RANGE OF 2.0 TO 3.9 NG/ML: VALUE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN ON TUMOR DETECTION AND TUMOR AGGRESSIVENESS
- 1 June 2004
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 171 (6 Part 1) , 2245-2249
Abstract
Purpose: We evaluated the positive predictive value and cancer detection rate in the prostate specific antigen (PSA) range of 2.0 to 3.9 ng/ml and assessed the value of percent free (F) PSA...Keywords
This publication has 18 references indexed in Scilit:
- Effect of Verification Bias on Screening for Prostate Cancer by Measurement of Prostate-Specific AntigenNew England Journal of Medicine, 2003
- Verification Bias and the Prostate-Specific Antigen Test — Is There a Case for a Lower Threshold for Biopsy?New England Journal of Medicine, 2003
- PROSTATE CANCER DETECTION AT LOW PROSTATE SPECIFIC ANTIGENJournal of Urology, 2000
- Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam Region)The Prostate, 1999
- Prospective Evaluation of Men With Stage T1C Adenocarcinoma of the ProstateJournal of Urology, 1997
- The Free-To-Total Prostate Specific Antigen Ratio Improves the Specificity of Prostate Specific Antigen in Screening for Prostate Cancer in the General PopulationJournal of Urology, 1997
- Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and ageUrology, 1996
- The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 menUrology, 1995
- European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam Pilot studiesCancer, 1995
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer1994